Gilead CEO Milligan capped a rocky year — and his career — with the new #1 compensation package in the big leagues of biopharma
Gilead’s recently departed CEO John Milligan capped a year marked by setbacks, a major write-off and big questions about the company’s future under a new helmsman with what currently stands as the biggest pay package of all the major league CEOs in biopharma.
Image: John Milligan speaks to Bloomberg in 2014 Bloomberg
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
